Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change updates the page's revision history metadata.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe change reflects an update to the ClinicalTrials.gov record history page/versioning and revision label rather than substantive changes to the study information itself.SummaryDifference0.5%

- Check41 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study record history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 in the Record History page.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision (v3.4.3) was added to the Record History, and the previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.